Skip to main navigation Skip to search Skip to main content

A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab

Research output: Contribution to journal › Article › peer-review

9   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience